Legal & General Group
ASXC

Legal & General Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Legal & General Group’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,557
Closed -$13K – 3697
2022
Q1 		$13K Hold
20,557
– – ﹤0.01% 3348
2021
Q4 		$23K Hold
20,557
– – ﹤0.01% 3237
2021
Q3 		$38K Hold
20,557
– – ﹤0.01% 3056
2021
Q2 		$65K Buy
+20,557
New +$51.4K ﹤0.01% 2875
2020
Q2 		– Sell
-2,952
Closed -$1K – 3480
2020
Q1 		$1K Hold
2,952
– – ﹤0.01% 3345
2019
Q4 		$4K Buy
2,952
+97
+3% +$337 ﹤0.01% 3349
2019
Q3 		$23K Hold
2,855
– – ﹤0.01% 3094
2019
Q2 		$47K Buy
2,855
+509
+22% +$11.1K ﹤0.01% 2804
2019
Q1 		$72K Buy
2,346
+149
+7% +$4.99K ﹤0.01% 2603
2018
Q4 		$64K Buy
2,197
+312
+17% +$14.2K ﹤0.01% 2598
2018
Q3 		$142K Buy
1,885
+95
+5% +$6.43K ﹤0.01% 2411
2018
Q2 		$101K Buy
+1,790
New +$65.2K ﹤0.01% 2498
2017
Q2 		– Sell
-683
Closed -$11K – 3391
2017
Q1 		$11K Sell
683
-5
-0.7% -$87 ﹤0.01% 3182
2016
Q4 		$12K Buy
+688
New +$14.1K ﹤0.01% 3199

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Legal & General Group's ASXC Position: Q2 2022 in Review

Legal & General Group sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 20,557 shares — an estimated $13K sold.

Legal & General Group first reported a position in ASXC in Q4 2016 and held it in 14 quarters. The position peaked at $142K in Q3 2018. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Legal & General Group reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 20,557 Asensus Surgical, Inc. shares in Q2 2022, an estimated $13K.
  • Legal & General Group first reported a position in Asensus Surgical, Inc. in Q4 2016 and held it in 14 quarters.
  • Legal & General Group's Asensus Surgical, Inc. position peaked at $142K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.